Effects of controlled perioperative antimicrobial prophylaxis on infectious outcomes in pediatric cardiac surgery

Critical Care Medicine

Volumn 35, Issue 7, 2007, Pages 1763-1768

  Kato, Yuko ^a   Shime, Nobuaki ^a,b   Hashimoto, Satoru ^a   Nomura, Mayuko ^a   Okayama, Yoko ^a   Yamagishi, Masaaki ^a   Fujita, Naohisa ^a  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Antimicrobial prophylaxis; Glycopeptides; Methicillin resistant Staphylococcus aureus; Pediatric cardiac surgery

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; GLYCOPEPTIDE; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; FEMALE; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PSEUDOMONAS AERUGINOSA; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

EID: 34250812521     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000269027.50834.FE     Document Type: Article

References (34)

1. Kollef MH, Sharpless L, Vlasnik J, et al: The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 1997; 112:666-675
2. Urrea M, Pons M, Serra M, et al: Prospective incidence study of nosocomial infections in a pediatric intensive care unit. Pediatr Infect Dis J 2003; 22:490-494
3. American Society of Health-System Pharmacists: ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 1999; 56:1839-1888
4. Bratzler DW, Houck PM: Antimicrobial prophylaxis for surgery: An advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189:395-404
5. Edwards FH, Engelman RM, Houck P, et al: The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part I: Duration. Ann Thorac Surg 2006; 81:397-404
6. Mangram AJ, Horan TC, Pearson ML, et al: Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27:97-132
7. Bratzler DW, Houck PM, Richards C, et al: Use of antimicrobial prophylaxis for major surgery: Baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005; 140:174-182
8. Sekimoto M, Imanaka Y, Evans E, et al: Practice variation in perioperative antibiotic use in Japan. Int J Qual Health Care 2004; 16:367-373
9. Yamamoto S, Kanamaru S, Kunishima Y, et al: Perioperative antimicrobial prophylaxis in urology: A multi-center prospective study. J Chemother 2005; 17:189-197
10. Finkelstein R, Rabino G, Mashiah T, et al: Surgical site infection rates following cardiac surgery: The impact of a 6-year infection control program. Am J Infect Control 2005; 33:450-454
11. McConkey SJ, L'Ecuyer PB, Murphy DM, et al: Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol 1999; 20:533-538
12. Zanetti G, Goldie SJ, Platt R: Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: Example of coronary artery bypass surgery. Emerg Infect Dis 2001; 7:820-827
13. Jenkins KJ, Newburger JW, Lock JE, et al: In-hospital mortality for surgical repair of congenital heart defects: Preliminary observations of variation by hospital caseload. Pediatrics 1995; 95:323-330
14. Horan TC, Gaynes RP: Surveillance of Nosocomial Infections. Philadelphia, Lippincott Williams & Wilkins, 2004
15. Levy I, Ovadia B, Erez E, et al: Nosocomial infections after cardiac surgery in infants and children: Incidence and risk factors. J Hosp Infect 2003; 53:111-116
16. Mehta G, Khanna SK, Trehan H, et al: Postoperative infection in cardiac surgery: The influence of a change in prophylactic antibiotic regimen. J Hosp Infect 1990; 15:353-362
17. Mehta PA, Cunningham CK, Colella CB, et al: Risk factors for sternal wound and other infections in pediatric cardiac surgery patients. Pediatr Infect Dis J 2000; 19:1000-1004
18. Nateghian A, Taylor G, Robinson JL: Risk factors for surgical site infections following open-heart surgery in a Canadian pediatric population. Am J Infect Control 2004; 32:397-401
19. Tortoriello TA, Friedman JD, McKenzie ED, et al: Mediastinitis after pediatric cardiac surgery: A 15-year experience at a single institution. Ann Thorac Surg 2003; 76:1655-1660
20. Diekema DJ, Pfaller MA, Schmitz FJ, et al: SENTRY Participants Group. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2):S114-S132
21. Carrier M, Marchand R, Auger P, et al: Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J Thorac Cardiovasc Surg 2002; 123:40-44
22. Finkelstein R, Rabino G, Mashiah T, et al: Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 2002; 123:326-332
23. Muto CA, Jernigan JA, Ostrowsky BE, et al: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-386
24. Banbury MK: Experience in prevention of sternal wound infections in nasal carriers of Staphylococcus aureus. Surgery 2003; 134:S18-S22
25. Casewell MW: The nose: An underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect 1998; 40(Suppl B):S3-S11
26. Allpress AL, Rosenthal GL, Goodrich KM, et al: Risk factors for surgical site infections after pediatric cardiovascular surgery. Pediatr Infect Dis J 2004; 23:231-234
27. Kreter B, Woods M: Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg 1992; 104:590-599
28. Harbarth S, Samore MH, Lichtenberg D, et al: Is prolonged antibiotic prophylaxis after major surgery associated with an increased risk of nosocomial bloodstream infection? J Am Coll Surg 2000; 190:503-504
29. Takesue Y, Yokoyama T, Akagi S, et al: Changes in the intestinal flora after the administration of prophylactic antibiotics to patients undergoing a gastrectomy. Surg Today 2002; 32:581-586
30. Garrouste-Orgeas M, Marie O, Rouveau M, et al: Secondary carriage with multi-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: Relationship with nosocomial infections and mortality. J Hosp Infect 1996; 34:279-289
31. Silvestri L, van Saene HK, Milanese M, et al: Prevention of MRSA pneumonia by oral vancomycin decontamination: A randomised trial. Eur Respir J 2004; 23:921-926
32. Fischer JE, Ramser M, Fanconi S: Use of antibiotics in pediatric intensive care and potential savings. Intensive Care Med 2000; 26:959-966
33. Namias N, Harvill S, Ball S, et al: Cost and morbidity associated with antibiotic prophylaxis in the ICU. J Am Coll Surg 1999; 188:225-230
34. Haddadin AS, Fappiano SA, Lipsett PA: Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J 2002; 78:385-389